1. Home
  2. ALNY
  3. ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on January 22, 2025

New Strong Buy Stocks for January 21st
ALNY

Zacks

a day ago

New Strong Buy Stocks for January 21st

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals
ALNY

Zacks

9 days ago

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals
ALNY

Business Wire

10 days ago

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference
ALNY

Business Wire

16 days ago

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks in the US December 2024
ALNY

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks in the US December 2024

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
ALNY

Zacks

a month ago

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?
ALNY

Insider Monkey

a month ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam
ALNY

Zacks

a month ago

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam

4 Biotech Stocks Most Wall Street Analysts Are Bullish About
ALNY

Zacks

a month ago

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

ALNY

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study
ALNY

Zacks

a month ago

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study

What Makes Alnylam (ALNY) a New Buy Stock
ALNY

Zacks

2 months ago

What Makes Alnylam (ALNY) a New Buy Stock

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?
ALNY

Zacks

2 months ago

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?
ALNY

Insider Monkey

2 months ago

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?

ALNY

MT Newswires

2 months ago

Mirae Asset Downgrades Alnylam Pharmaceuticals to Hold, Price Target is $236

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference
ALNY

Business Wire

2 months ago

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

Kronos, Idorsia plan layoffs; PTC shelves ALS drug
ALNY

BioPharma Dive

2 months ago

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
ALNY

Zacks

2 months ago

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug
ALNY

Investor's Business Daily

2 months ago

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug

Exploring Three High Growth Tech Stocks In The United States
ALNY

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks In The United States

ALNY

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

ALNY

MT Newswires

2 months ago

Alnylam Says FDA Accepts Supplemental NDA for Vutrisiran to Treat ATTR Amyloidosis With Cardiomyopathy

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

2 months ago

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

BridgeBio heart drug approved by FDA, setting up battle with Pfizer
ALNY

BioPharma Dive

2 months ago

BridgeBio heart drug approved by FDA, setting up battle with Pfizer

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
ALNY

Zacks

2 months ago

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
ALNY

Clinical Trials Arena

2 months ago

Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Says Nucresiran Performed Well in Phase 1 Transthyretin Amyloidosis Study

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
ALNY

Business Wire

2 months ago

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Shares Fall After Wolfe Downgrade

ALNY

MT Newswires

2 months ago

Wolfe Downgrades Alnylam Pharmaceuticals to Underperform From Peer Perform, Price Target at $205

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%
ALNY

Simply Wall St.

2 months ago

3 US Stocks Estimated To Be Trading At Discounts Up To 48.8%

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
ALNY

Pharmaceutical Technology

3 months ago

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

An RNAi renaissance is creating a new generation of startups
ALNY

BioPharma Dive

3 months ago

An RNAi renaissance is creating a new generation of startups

Alnylam to Webcast Presentations at Upcoming November Investor Conferences
ALNY

Business Wire

3 months ago

Alnylam to Webcast Presentations at Upcoming November Investor Conferences

ALNY

Morningstar Research

3 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
ALNY

Zacks

3 months ago

Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
ALNY

GuruFocus.com

3 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
ALNY

GuruFocus.com

3 months ago

Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight

ALNY

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say
ALNY

Zacks

3 months ago

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates
ALNY

Zacks

3 months ago

Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Net Loss, Revenue Falls

ALNY

Associated Press Finance

3 months ago

Alnylam: Q3 Earnings Snapshot

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity
ALNY

Business Wire

3 months ago

Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Cognizant signs deal to enhance Alnylam’s IT infrastructure
ALNY

Verdict

3 months ago

Cognizant signs deal to enhance Alnylam’s IT infrastructure

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024
ALNY

Business Wire

3 months ago

Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024

ALNY

MT Newswires

3 months ago

Cognizant Selected as Alnylam's IT Services Provider

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
ALNY

Zacks

3 months ago

Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
ALNY

Zacks

3 months ago

Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
ALNY

Zacks

3 months ago

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?
ALNY

Zacks

3 months ago

Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B
ALNY

Zacks

3 months ago

NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
ALNY

Zacks

3 months ago

FOLD Stock Rises on Settling Galafold Patent Dispute With Teva

High Growth Tech Stocks to Watch in October 2024
ALNY

Simply Wall St.

3 months ago

High Growth Tech Stocks to Watch in October 2024

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
ALNY

Zacks

3 months ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
ALNY

Zacks

3 months ago

Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
ALNY

Business Wire

3 months ago

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

ALNY

MT Newswires

3 months ago

Alnylam Submits Regulatory Application to EMA for ATTR Amyloidosis With Cardiomyopathy Treatment

ALNY

MT Newswires

3 months ago

Scotiabank Initiates Alnylam Pharmaceuticals at Sector Outperform With $305 Price Target

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

3 months ago

Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
ALNY

Zacks

3 months ago

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

3 US Stocks Estimated To Be Trading At Up To 46.6% Discount
ALNY

Simply Wall St.

3 months ago

3 US Stocks Estimated To Be Trading At Up To 46.6% Discount

Biotech Eyes Early Entry As Several Factors Could Unleash Shares
ALNY

Investor's Business Daily

3 months ago

Biotech Eyes Early Entry As Several Factors Could Unleash Shares

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA
ALNY

Zacks

3 months ago

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals Files Supplemental New Drug Application With FDA for Vutrisiran

Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
ALNY

Business Wire

3 months ago

Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy

Protein prediction wins chemistry Nobel; Alnylam submits an all-important drug application
ALNY

BioPharma Dive

3 months ago

Protein prediction wins chemistry Nobel; Alnylam submits an all-important drug application

RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag
ALNY

Zacks

3 months ago

RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy Tag

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy

Startup led by John Maraganore raises $135M to build ‘future of RNAi’
ALNY

BioPharma Dive

3 months ago

Startup led by John Maraganore raises $135M to build ‘future of RNAi’

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
ALNY

BioPharma Dive

4 months ago

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Is Expected To Breakeven In The Near Future
ALNY

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Is Expected To Breakeven In The Near Future

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
ALNY

Zacks

4 months ago

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
ALNY

Zacks

4 months ago

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
ALNY

Insider Monkey

4 months ago

Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance

ALNY

MT Newswires

4 months ago

Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
ALNY

Business Wire

4 months ago

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024

Alnylam to Webcast TTR Investor Day
ALNY

Business Wire

4 months ago

Alnylam to Webcast TTR Investor Day

ALNY

MT Newswires

4 months ago

China Merchants Initiates Alnylam Pharmaceuticals at Buy With $360 Price Target

ALNY

MT Newswires

4 months ago

Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says

High Growth Tech Stocks To Watch In September 2024
ALNY

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In September 2024

Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock
ALNY

Insider Monkey

4 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Three Stocks That Might Be Undervalued In September 2024
ALNY

Simply Wall St.

4 months ago

Three Stocks That Might Be Undervalued In September 2024

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
ALNY

The Wall Street Journal

4 months ago

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly

Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?
ALNY

Insider Monkey

4 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY Down Despite Positive Data From Heart Disease Drug Study
ALNY

Zacks

5 months ago

ALNY Down Despite Positive Data From Heart Disease Drug Study

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy
ALNY

Simply Wall St.

5 months ago

Alnylam Pharmaceuticals Insiders Sold US$5.0m Of Shares Suggesting Hesitancy

Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
ALNY

Investor's Business Daily

5 months ago

Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged

ESC Congress: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
ALNY

Pharmaceutical Technology

5 months ago

ESC Congress: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam

ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
ALNY

Pharmaceutical Technology

5 months ago

ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam

Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug
ALNY

The Wall Street Journal

5 months ago

Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug

Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations
ALNY

Investor's Business Daily

5 months ago

Alnylam Plummets, Reversing 50% Gain This Year, As Pfizer Rival Lags Expectations

ALNY

MT Newswires

5 months ago

Alnylam Pharmaceuticals Reports Substantial Results of Vutrisiran's Phase 3 Study as Heart Disease Therapy

Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
ALNY

Business Wire

5 months ago

Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress

Share on Social Networks: